tldrdaily.news logo
Tag

Jn1 Subvariant

All articles tagged with #jn1 subvariant

health1 year ago

"Study: Latest Covid Vaccine Shows 54% Effectiveness Against Symptomatic Infection"

New data from the CDC suggests that the most recent Covid-19 booster provides about 54% protection against infection, with similar effectiveness against the targeted XBB.1.5 strain and the dominant JN.1 subvariant. Vaccine effectiveness was 58% for those tested 7-59 days after receiving the shot and 49% for those tested 60-119 days after. Waning effectiveness over time is expected, but the updated vaccine still offers significant protection, especially for high-risk individuals. Experts compare the efficacy to flu vaccines and emphasize the importance of getting the latest vaccine version, particularly for those at highest risk.

via STAT|
#booster-shot#cdc#covid-19
health2 years ago

China Issues Warning on Potential Covid-19 Subvariant Rebound

Chinese health authorities have warned of a potential resurgence of COVID-19 driven by the JN.1 subvariant, which is on the rise due to factors like imported cases, lower influenza rates, and declining population immunity. Despite low current COVID-19 burden, hospitals are preparing for a potential surge, and high-risk groups are advised to prioritize annual influenza vaccination and maintain healthy habits.

via CGTN|
#china#covid-19#health
health-covid-192 years ago

"Delays in At-Home COVID Test Results Amid Rising Cases"

With COVID-19 cases rising, at-home tests may take longer to show positive results due to accumulated immunity from vaccinations or previous infections. The CDC recommends testing immediately if symptomatic, and retesting if initially negative. Asymptomatic individuals exposed to the virus should test five days after exposure and follow up with additional tests. A more contagious subvariant, JN.1, is contributing to the spread of COVID-19. Free at-home tests are available through various government programs, and healthcare coverage may impact the cost of testing.

via Anchorage Daily News|
#at-home-tests#covid-19#health-covid-19
health2 years ago

Rapid Spread of Highly Contagious JN.1 COVID-19 Variant Raises Concerns in U.S.

The JN.1 subvariant of COVID-19 is rapidly spreading and becoming the dominant strain on Long Island and across the state of New York, coinciding with an increase in cases and hospitalizations during the holiday season. The subvariant, which evolved from the BA. 2.86 variant, is highly transmissible but does not cause more severe disease. However, vaccination rates remain low, with only around 8% of Long Islanders receiving the most recent vaccine dose. Medical experts emphasize the importance of staying up-to-date on COVID vaccinations, as well as flu and RSV vaccines, to protect against the "tripledemic" of COVID, flu, and RSV.

via Newsday|
#covid-19#health#hospitalizations
health2 years ago

Navigating the Triple Threat: Staying Healthy Amid Rising Covid, Flu, and RSV Cases

The JN.1 subvariant of the coronavirus is now the fastest growing strain in the US, constituting about 20% of new Covid-19 infections. Hospitalizations for influenza, RSV, and Covid-19 have increased significantly in the past four weeks. Vaccination rates for the flu and RSV remain low. To stay healthy this holiday season, individuals should consider getting vaccinated against these viruses and taking precautions based on their medical circumstances. Event organizers can improve safety by improving ventilation, offering outdoor options, and providing hand sanitizer. It is important to remember that vaccination is crucial in protecting vulnerable individuals from severe disease.

via CNN|
#covid-19#flu#health
health2 years ago

Rapid Spread of COVID Subvariant JN.1 Raises Concerns in US and Northeast

The JN.1 subvariant of the coronavirus is rapidly spreading in the US and has become dominant in the Northeast, causing about 20% of new infections nationwide. Descended from the BA.2.86 subvariant, JN.1 has only one change to its spike protein but is proving to be a fitter and faster virus. Studies suggest a twofold decrease in the ability of antibodies to neutralize JN.1, potentially leading to another wave of infections. The subvariant is growing quickly in several countries, including Europe, Australia, Asia, and Canada. Waning immunity and low vaccination rates contribute to its spread. The current Covid-19 vaccine offers good protection against JN.1 and its offshoots, emphasizing the importance of vaccination.

via CNN|
#covid-19#health#immunity
health2 years ago

Rapid spread of JN.1 variant prompts increased surveillance and mask mandates in Kerala and Karnataka

As Covid-19 cases rise in Kerala, surveillance has been increased in Maharashtra following the detection of the JN.1 subvariant. The majority of cases in Kerala are clinically mild and recovering at home, but public health measures are being implemented to minimize transmission risks during the upcoming festive season. District health authorities in Maharashtra have been directed to evaluate hospital readiness, establish isolation wards, and conduct regular surveillance of Covid-19 and influenza cases. Sewage-waste water sampling is also being conducted for timely detection of new variants. The JN.1 subvariant, classified as a variant of interest by the World Health Organization, has not shown an increase in hospitalization so far.

via The Indian Express|
#covid-19#health#hospital-readiness
health2 years ago

COVID-19 Subvariant JN.1 Alert: Guidelines for Christmas, New Year and Mask Mandate for Seniors in Karnataka

The Health Ministry has issued an alert to states regarding the new COVID-19 subvariant, JN.1, which is currently spreading in Kerala. While it is not yet known if JN.1 causes different symptoms or is more severe than other variants, the existing treatment line for COVID-19 is expected to be effective against it. RT-PCR tests are recommended for detecting JN.1. With the upcoming festive season, the Health Ministry emphasizes the need for adhering to respiratory hygiene norms, including wearing masks, frequent hand-washing, and social distancing. Increased surveillance and monitoring of influenza-like illness and severe respiratory cases are also being implemented. JN.1 has been reported in several countries and is raising concerns due to its rapid spread and immunity-evading capacity.

via The Indian Express|
#covid-19#health#health-ministry
health2 years ago

Karnataka and Kerala Take Action Against Covid Surge

The Karnataka government has made it mandatory for individuals above 60 years of age and those with comorbidities to wear face masks amid the growing scare of the Covid-19 subvariant JN.1 in neighboring Kerala. The state has increased testing and surveillance in border districts with Kerala, but there are currently no restrictions on movement or gatherings. The JN.1 variant, also known as Omicron subvariant BA.2.86 or Pirola, has mild symptoms and high transmissibility. India has recorded 260 new Covid-19 infections, with the total case tally at 4.50 crore.

via Mint|
#covid-19#face-masks#health
health2 years ago

Kerala Reports U.S.-Prevalent JN.1 Subvariant of Omicron Spreading Ahead of Holidays

Kerala has reported the presence of the JN.1 subvariant of the Omicron variant, raising concerns about COVID-19. However, experts have stated that there is no need to worry at this moment, emphasizing the importance of continuous monitoring. The JN.1 subvariant, part of the BA.2.86 lineage, was first detected in Luxembourg and has immune-evasion properties. While it exhibits symptoms such as fever, coughing, and nasal congestion, there have been no severe cases or deaths associated with it. The World Health Organization classifies it as a "notable descendent lineage" with potential increased transmissibility, but the Centers for Disease Control and Prevention currently reports no evidence of increased public health risk or severity compared to other variants.

via The Weather Channel|
#continuous-monitoring#covid-19#health
health2 years ago

Omicron Variant Surges Amidst Winter Covid Wave

A new subvariant of the Omicron variant, JN.1 or "Pirola," is rapidly spreading in New Zealand, accounting for one in 10 cases sequenced. It is uncertain whether JN.1 will outcompete the EG.5 subvariant that has been dominant in the pre-Christmas wave. JN.1, which is now responsible for about a third of cases in the UK and US, has a single change in its spike protein compared to BA.2.86. While JN.1 may have gained extra transmissibility, there is no evidence of increased severity. The current wave in New Zealand has led to a surge in vaccinations, but cases are expected to increase further during the pre-Christmas period. The emergence of a completely new variant would require a substantial leap in evolution.

via Otago Daily Times|
#christmas-party-season#covid-19#health